BIO Early-Stage Resources Hub

Access a range of exclusive resources, including cost-saving programs, educational webinars and stay up-to-date with the latest BIO Emerging Companies Section (ECS) events with our comprehensive resource center, designed to empower early-stage companies and help them thrive.

  • Show All
Results
PDF
BIO Large Biopharma Therapeutic Focus Guide
FLIP
This resource provides guidance to assist early-stage companies in identifying potential large biopharma partners.
FLIP
PDF
BIO Letter to Senate Banking Cmte: Proposals to Foster Capital Formation and Economic Growth in the Bioeconomy (3/18/2021)
FLIP
BIO Letter to Senate Banking Committee in support of proposals to foster capital formation for biotechs.
FLIP
PDF
BIO Office Hours: Grant Writing Slides
FLIP
A PowerPoint presentation on the grant application process. An overview of how to identify opportunities, how to compose a proposal, and project management tips.
FLIP
PDF
BIO Tax Priorities Overview (7/6/2023)
FLIP
An overview of BIO’s tax policy priorities.
FLIP
PDF
Cybersecurity Risk Management, Strategy, Governance, and Incident Disclosure (5/5/2022)
FLIP
Comments on proposed rule to enhance and standardize disclosures regarding cybersecurity risk management, strategy, governance, and incident reporting by public companies.
FLIP
PDF
FTC Comment Letter: Business Practices of Pharmacy Benefit Managers and Their Impact on Independent Pharmacies and Consumers (5/5/2022)
FLIP
Comments in response to FTC Solicitation for Public Comments on the Business Practices of Pharmacy Benefit Managers and Their Impact on Independent Pharmacies and Consumers.
FLIP
PDF
FTC Comment Letter: Request for Comment on Pharmaceutical Task Force, Project No. P212900 (6/13/2021)
FLIP
Comments in response to Federal Trade Commission’s Pharmaceutical Task Force’s request for public comment.
FLIP
PDF
FTC Comment Letter: Request for Information on Merger Enforcement (4/15/2022)
FLIP
Comments to FTC on merger enforcement.
FLIP
PDF
IRA’s Impact on the US Biopharma Ecosystem
FLIP
New research released by Vital Transformation (VT) shows that the Inflation Reduction Act (IRA) will stifle the ability of companies to continue research and development across a broad range of therapeutic areas.
FLIP
PDF
Letter to House & Senate Leaders: R&D Amortization (5/4/2023)
FLIP
BIO and BIO members urge immediate legislative action to repeal the harmful R&D amortization provision that went into effect in 2022.
FLIP
PDF
Letter to House & Senate Leaders: R&D Amortization (6/15/2022)
FLIP
BIO, BIO members, and State affiliates urge immediate legislative action to repeal the harmful R&D amortization provision that went into effect in 2022.
FLIP
PDF
Minimum Pricing Increments, Access Fees, and Transparency of Better Priced Orders (3/30/2023)
FLIP
Comments on proposed rule to adapt a variable minimum pricing increments for the quoting and trading of NMS stocks, reduce access fee caps, and enhance transparency of better priced orders.
FLIP
PDF
PSC Biotech: Grant Writing White Paper
FLIP
A white paper on regulatory grant writing, best practices for developing proposals, success factors, and tackling grant writing challenges.
FLIP
PDF
Request for Comment on Proposed Amendments to Rules Governing Proxy Voting Advice (12/23/2021)
FLIP
Comments on proposed rule governing proxy voting advice.
FLIP
PDF
SBIR Application Key Decision Points Flowchart
FLIP
A grant application flowchart from start to finish. Includes decision points and scenarios to help determine which agencies and grants to apply to.
FLIP
PDF
SEC Comment Letter: Order Competition Rule (3/30/2023)
FLIP
Comments on proposed rule to amend regulations governing the national market system (NMS).
FLIP
PDF
SEC Comment Letter: Request for Comment on Climate Risk Disclosures (6/13/2021)
FLIP
Comments on SEC request for information on climate risk disclosures.
FLIP
PDF
SEC Comment Letter: Short Position and Short Activity Reporting (4/25/2022)
FLIP
Comments on proposed rule to require money managers to disclose within 14 calendar days after month-end certain gross short positions on companies.
FLIP
PDF
Statement for the Record: "A Roadmap for Growth: Reforms to Encourage Capital Formation and Investment Opportunities for All Americans" (4/23/2023)
FLIP
Statement for the Record to House Financial Services Committee, Subcommittee on Capital Markets.
FLIP
PDF
Talking Points: Impact of Domestic R&D Amortization on the Biotechnology Community (4/21/2023)
FLIP
Talking points on the background, impact on the biotechnology community and solution.
FLIP